Warmuth Markus (CIK 1855643) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-02). Recent activity: Sell GLUE (4,998 shares), Sell GLUE (468 shares), Sell GLUE (8,000 shares), Sell GLUE (5,466 shares), Sell GLUE (3,707 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 4,998 | $97,021 |
| 2026-06-02 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 468 | $9,232 |
| 2026-04-15 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 8,000 | $141,125 |
| 2026-03-04 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 5,466 | $97,951 |
| 2026-01-09 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 3,707 | $86,151 |
| 2026-01-09 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 1,450 | $34,626 |
| 2026-01-09 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 309 | $7,592 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Buy | 90,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | President & CEO | Sell | 10,135 | $153,748 |
Source: SEC Form 4 filings · as of 2026-06-02